<DOC>
	<DOCNO>NCT01268865</DOCNO>
	<brief_summary>Background : In patient chronic liver disease , liver fibrosis stag crucial hazard evaluation future disease complication development thus optimal decision make treatment selections.In era antiviral antifibrotic treatment , clinical research demand also increase non-invasive surveillance liver fibrosis evaluate progression regression . However , local baseline data liver stiffness measurement ( LSM ) use ARFI technique still lack Taiwan , viral hepatitides highly endemic . Aim : Using ARFI elastosonography , dedicate aim recruit patient base strict appropriate criterion , complete correlation validity study ARFI quantification reference METAVIR fibrosis score conduct subsequent innovative study liver disease . Materials Methods : We plan perform ARFI quantification HBV HCV-infected patient immediately follow priorly schedule conventional liver biopsy METAVIR score session examination . Statistics : The first year 's study use ARFI focus correlation testing validity study use receiver operate characteristic .</brief_summary>
	<brief_title>Acoustic Radiation Force Impulse ( ARFI ) Technology Prediction Liver Fibrosis</brief_title>
	<detailed_description>Contribution Future Works : Using ARFI quantification either causal factor outcome , conduct future analysis range validation , regression prospective time-to-event analysis among cohort .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>infect HBV HCV concurrent HBVHCV infection , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Acoustic Radiation Force Impulse ( ARFI )</keyword>
	<keyword>Virtual Touch Quantification ( VTQ )</keyword>
	<keyword>liver stiffness measurement ( LSM )</keyword>
	<keyword>liver fibrosis</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>hepatitis B</keyword>
	<keyword>hepatitis C</keyword>
</DOC>